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A community-based transcriptomics 
classification and nomenclature of neocortical 
cell types
To understand the function of cortical circuits, it is necessary to catalog their cellular diversity. Past attempts to do 
so using anatomical, physiological or molecular features of cortical cells have not resulted in a unified taxonomy 
of neuronal or glial cell types, partly due to limited data. Single-cell transcriptomics is enabling, for the first time, 
systematic high-throughput measurements of cortical cells and generation of datasets that hold the promise of 
being complete, accurate and permanent. Statistical analyses of these data reveal clusters that often correspond 
to cell types previously defined by morphological or physiological criteria and that appear conserved across 
cortical areas and species. To capitalize on these new methods, we propose the adoption of a transcriptome-based 
taxonomy of cell types for mammalian neocortex. This classification should be hierarchical and use a standardized 
nomenclature. It should be based on a probabilistic definition of a cell type and incorporate data from different 
approaches, developmental stages and species. A community-based classification and data aggregation 
model, such as a knowledge graph, could provide a common foundation for the study of cortical circuits. This 
community-based classification, nomenclature and data aggregation could serve as an example for cell type atlases 
in other parts of the body.
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Classifications of cortical cell types: 
from Cajal to the Petilla Convention
The conceptual foundation of modern 
biology is the cell theory of Virchow, 
which described the cell as the basic unit 
of structure, reproduction and pathology 
of biological organisms1. This idea, which 
arose from the use of microscopes by 
Leeuwenhoek, Hooke, Schleiden and 
Schwann, among others, generated the need 
to build catalogs of the cellular components 
of tissues as the first step toward studying 
their structure and function. As with 
species, these cell catalogs, or atlases, can be 
ideally systematized into ‘cell taxonomies’, 
classifying groups of cells based on  
shared characteristics and grouping them 
into taxa with ranks and a hierarchy. 
Taxonomies are important: they provide 
a conceptual foundation for a field and 
also enable the systematic accumulation 
of knowledge. Essential to this effort is 
the clear definition of cell type, normally 
understood as cells with shared phenotypic 
characteristics.
Virchow’s cell theory was introduced 
to neuroscience by Cajal, whose ‘neuron 
doctrine’ postulated that the structural unit 
of the nervous system was the individual 
neuron2. Since then, generations of 
investigators have described hundreds of cell 
types in nervous systems of different species. 
This effort has been particularly arduous 
in the cerebral cortex (or neocortex), the 
largest part of the brain in mammals and the 
primary site of higher cognitive functions. 
The mammalian neocortex has a thin 
layered structure, composed of mixtures of 
excitatory and inhibitory neurons arranged 
in circuits of a forbidding complexity, called 
“impenetrable jungles” by Cajal3. This basic 
structure is very similar in different cortical 
areas and in different species, which has 
given rise to the possibility that there is a 
‘canonical’ cortical microcircuit4–7, replicated 
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during evolution, which underlies all 
cortical function.
After more than a hundred years of 
sustained progress, it is clear that neocortical 
neurons and glial cells, like cells in any 
tissue, belong to many distinct types. 
Different cell types likely play discrete 
roles in cortical function and computation, 
making it important to characterize and 
describe them accurately and in their 
absolute and relative numbers. Towering 
historical figures like Cajal, Lorente de Nó 
and Szentágothai, among others, proposed 
classifications of cortical cells based on their 
morphologies as visualized with histological 
stains4,8,9 (Fig. 1a–c). These anatomical 
classifications described several dozen types 
of pyramidal neurons, short-axon cells 
and glial cells, and they were subsequently 
complemented by morphological accounts 
of additional cortical cell types by many 
researchers10–12, but without arriving at a 
clear consensus as to the number or even the 
definition of a cortical cell type.
Over the last few decades, the 
introduction of new morphological, 
ultrastructural, immunohistochemical 
and electrophysiological methods, new 
molecular markers, and a growing 
appreciation of the developmental origins  
of distinct neuronal subtypes (Fig. 1d–h),  
have provided increasingly finer 
phenotypic measurements of cortical cells 
and enabled new efforts to classify them 
more quantitatively, using supervised or 
unsupervised methods such as cluster 
analysis13–16. A community effort to classify 
neocortical inhibitory cells was attempted at 
the 2005 Petilla Convention, held in Cajal’s 
hometown in Spain, and led to a common 
standardized terminology describing the 
anatomical, physiological and molecular 
features of neocortical interneurons17. 
While useful, this fell short of providing 
a classification and working framework 
that investigators could incorporate into 
their research. One reason why this early 
effort failed was because the datasets for 
phenotypically characterizing cortical 
neurons were small. Indeed, many of the 
early studies are based on characterizing 
dozens or at most hundreds of neurons, 
small samples from the nearly 20 billion in 
human neocortex18.
An outcome of the Petilla Convention 
was the realization that there was not yet a 
single method that captured the inherently 
multimodal nature of cell phenotypes and 
could serve as a standard for classification. 
While most researchers accepted the 
existence of cell types that could be 
measured and defined independently 
by different methods, there was no 
agreement as to which would form an 
optimal basis for classification. In principle, 
many criteria can be used, including 
(i) anatomical or connectivity-based 
features19,20, (ii) parametrization of intrinsic 
electrophysiological properties21,  
(iii) combination of structural and 
physiological criteria22,23, (iv) molecular 
markers14,24,25, (v) developmental origins26,27, 
(vi) epigenetic attractor states28 or  
(vii) evolutionary approaches identifying 
homology across species29,30. Ideally, these 
classifications should converge and agree, 
or at least substantially overlap. Indeed, 
there is substantial concordance among 
categories based on anatomical, molecular 
and physiological criteria13,22,31–34, but it has 
not been easy to combine these approaches 
into a unified taxonomy. There are 
substantial differences between researchers 
in assigning neurons to particular types 
in the literature19, and even experts often 
disagree on what constitutes ground truth. 
For example, while most publications agree 
on what a chandelier cell is, the concept of 
basket cells, a major subtype of inhibitory 
neuron, is much less clear19.
This uncertainty is explained and 
exacerbated by technical challenges: 
conventional approaches have been 
laborious, low-throughput, frequently 
non-quantitative and generally plagued  
by an inability to sample cells in 
standardized and systematic ways. Thus, 
setting aside debates about the importance 
of various criteria and the nature or even 
existence of discrete cell types, it is not 
surprising that the cell-type problem has 
remained challenging.
transcriptomics: a new framework for 
classifying cortical cell types
Recent advances in high-throughput 
single-cell transcriptomics (scRNAseq) 
have changed the paradigm of cellular 
classification, offering a new quantitative 
genetic framework35–40. These approaches 
measure the expression profiles of thousands 
of genes from individual cells in large 
numbers, at relatively high speed and low 
cost. Related methods in epigenomics can 
identify sites of methylation and putative 
gene transcriptional regulation, essential to 
cell function and state. These new methods 
are an outcome from the methodological, 
conceptual and economic revolution 
created by the Human Genome Project41 
and have flourished with support from 
the BRAIN Initiative42,43. With genomes in 
hand, it is now feasible to generate entire 
transcriptomes (which include the sequence 
and structure of transcripts) from tissues 
and to scale these methods for amplifying 
RNA in single cells. Initially limited to  
only a few hundred cells per experiment, 
effective new methods have emerged for 
profiling thousands of cells or nuclei at a 
time44–48. With simultaneous computational 
advances for analyzing large sequence-based 
data49,50, it is now possible to systematically 
classify and characterize the diversity of 
neural cells in any tissue, including the 
neocortex (Fig. 2).
Conceptually, as much as the genome  
is the internal genetic description for  
each species, the transcriptome, as the 
complete set of genes being expressed, 
provides an internal code that can 
describe each cell within an organism in 
a spatiotemporal context. Practically, the 
scale of scRNAseq promises near-saturating 
analysis of complex cellular brain regions 
like the neocortex, providing, for the first 
time, a comprehensive and quantitative 
description of cellular diversity and 
the prospect of simplifying tissue cell 
composition to a finite number of cell 
types and states defined by statistical 
clustering. Importantly, however, these 
transcriptionally defined clusters represent 
a probabilistic description of cell types 
in a high-dimensional landscape of gene 
expression across all cells in a tissue, rather 
than a definition based on a small set of 
necessary and sufficient cellular markers or 
other features (see below).
The scale, precision and information 
content of these current methods now far 
outpace other classical methods of cellular 
phenotyping in neuroscience and have the 
potential to approach the complete, accurate 
and permanent (CAP) criteria cited by 
Brenner as the gold standard in biological 
science51. Indeed, major efforts now aim 
to generate a complete description of cell 
types based on molecular criteria across 
the neocortex (Allen Institute for Brain 
Science36,40), the whole brain (the National 
Institutes of Health (NIH) BRAIN Initiative 
Cell Census Network52) and even the whole 
body (the Human Cell Atlas53). Also, as the 
Human Genome Project offered a means for 
comparative analysis of orthologous genes 
across species, these efforts could define 
all or most cell types and states in humans 
and model organisms, with the possibility 
of extending them to a variety of species 
to understand the evolution of cell-type 
diversity. These large investments have 
the potential for a transformative effect on 
neuroscience, which will be accelerated by 
a formalization of a molecular classification 
and its adoption by the community. They 
also hold promise for the development 
of methods for querying circuit function 
by providing tools for the targeting and 
manipulation of particular subtypes.
Transcriptomic classification offers 
the following advantages as a framework 
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Stereotypy of neuron morphology Interneuron subclass molecular markers Molecular marker/physiology correspondence
Fig. 1 | Non-transcriptomics cortical cell-type classifications. a,b, morphological characterization and classification of neurons (a) and glial cells (b) by ramón 
y cajal (1904)4. c, Diagram showing the connections of different types of interneurons with pyramidal cells. Adapted from Szentágothai (1975)9. d, Definition 
of GAbAergic interneuron classes based on non-overlapping and combinatorial marker gene expression. e, correlation of firing properties with class markers. 
f, cortical cell type classification based on intrinsic firing properties (Petilla convention). g, complex relationships between cellular morphology, marker-gene 
expression and intrinsic firing properties based on multimodal analysis. h, comprehensive morphological and physiological classifications of cortical cell types. 
Images in a,b reprinted with permission from ref. 4, cajal Institute; in c, adapted with permission from ref. 9, elsevier; in d, adapted with permission from ref. 25, 
Oxford Univ. Press; in e, adapted with permission from ref. 14, Society for Neuroscience; in f and g, adapted with permission from refs. 17,21, respectively, Springer 
Nature; in h, adapted with permission from ref. 23, cell Press.
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for bounding the problem of cellular 
diversity53–56:
 1. High-throughput transcriptomics is 
very effective at allowing a systematic, 
comprehensive analysis of cellular di-
versity in complex tissues. Its quantita-
tive and high-throughput nature enables 
the adoption of rigorous definitions 
and criteria using datasets from tens of 
thousands to millions of cells.
 2. The genes expressed by a cell during its 
development and maturity ultimately 
underlie its structure and function, and 
so the transcriptome offers predictive 
power based on interpreting gene func-
tion. Other cellular phenotypes, includ-
ing morphology, are in part encoded by 
genes, rather than completely independ-
ent defining criteria57.
 3. A molecular definition of cell types 
allows the identification of cell-type 
markers and the creation of genetic 
tools to target, label and manipulate 
specific cell types58,59, thereby provid-
ing the means to standardize datasets 
obtained by different researchers.
 4. Transcriptomic data can also provide 
information about human diseases, by 
allowing a potential linkage between 
genes associated with disease and their 
cellular locus of action. By combining 
with genome-wide association studies 
(GWAS) that identify genes causally 
involved in the pathophysiology of a 
disease, cell-type transcriptomics-based 
data might lead to identification of 
mechanistically unresolved diseases as 
detected changes in expression levels of 
genes from key cell types60.
 5. Expression profiles allow quantita-
tive comparison of cell types across 
evolutionary or developmental times, 
enabling the alignment of cell types 
across species (based on conserved 
expression of homologous genes)61 and 
developmental stages (based on gradual 
developmental trajectories)62–64.
 6. Transcriptomics also enables comparing 
cell types across organs, as different or-
gans use similar genes. Thus, it could be 
used to classify all the cells in the body 
with a single method and framework53.
Indeed, initial transcriptomic studies  
of cortical tissue are already providing  
many biological insights. For example, 
scRNAseq analysis of mouse and human 
cortex identified a complex but finite set 
of ~100 molecularly defined cell types per 
cortical region that generally agree with prior 
literature on cytoarchitectural organization, 
developmental origins, functional properties 
and long-range projections65. Moreover, the 
hierarchical (agglomerative) taxonomy of 
transcriptomic cell types66, based on relative 
similarity between clusters, reflects these 
organizational principles. Viewed as a tree 
or dendrogram, the initial branches reflect 
major classes (neuronal vs non-neuronal; 
excitatory vs inhibitory), with finer splits 
reflecting more subtle variants of each 
class that reflect different developmental 
programs; for example, neocortical neurons 
are split into excitatory glutamatergic vs 
inhibitory GABAergic classes reflecting their 
different developmental origins in embryonic 
pallium vs subpallial proliferative regions, 
while the next splits in the GABAergic 
branch contain neurons generated by 
medial and caudal subdivisions of the 
ganglionic eminence and the preoptic area 
(Fig. 2a). These transcriptomic divisions are 
consistent with a long literature on cell fate 
specification of different GABAergic classes 
and the transcription factors involved in that 
process62–64,67 (Fig. 2b). Transcriptomics also 
allows quantitative analysis of developmental 
trajectories involved in this specification 
and maturation62–64 (Fig. 2c). Genes that 
differentiate neuronal classes are enriched 
for those involved in neuronal connectivity 
and synaptic communication, indicating  
they are predictive of selective cellular  
and circuit function37 (Fig. 2d). Finally,  
the same major transcriptomic classes of 
cortical GABAergic neurons are found  
in mammals and reptiles68 (Fig. 2e), 
suggesting deep conservation of cellular 
architecture and underlying mechanisms of 
molecular specification.
Correspondence of cell-type  
classifications across modalities
Proposing a transcriptomic-based 
classification for a field traditionally 
centered on cellular anatomy, physiology and 
synaptic connectivity is challenging unless 
such a classification correlates strongly with 
those features. Recent work in the retina is 
promising in this regard, where a large body 
of work has established a highly diverse 
set of anatomically, physiologically and 
functionally discrete cell types69 and where 
transcriptomic clusters strongly correlate 
with this prior knowledge35,69,70. For example, 
for mouse bipolar cells, a class comprising 
15 types of excitatory interneurons, there 
is essentially perfect correspondence 
between types defined by scRNAseq, 
high-throughput optical imaging of 
electrical activity, and serial section electron 
microscopy35. The spinal cord provides 
another good example of correspondence 
between scRNAseq and other cellular 
characteristics, including developmental 
origins and connectivity profiles71,72. 
Similarly, scRNAseq of mammalian 
hippocampus identifies neuronal cell types 
that were already described by anatomy and 
electrophysiology73,74.
Strong evidence for cross-modal 
correspondence in neocortical cell types is 
accumulating as well. An early application 
of cluster analysis of mouse layer 5 neurons 
showed correspondence between synaptic 
connectivity, morphology and even laminar 
position13. Almost perfect correlations  
were seen between major interneuron 
subclasses for molecular markers, axonal 
morphology and kinetics of synaptic inputs31 
(Fig. 3a). Within somatostatin-positive 
interneurons, morphological and 
electrophysiological subgroups were 
correlated22. Other more specific neuron 
types show concordance between scRNAseq, 
physiology and morphology, such as the 
‘rosehip’ cell, a layer 1 inhibitory neuron 
type in human cortex75 (Fig. 3b). Similarly, 
strong correspondence between scRNA-seq, 
electrophysiology and morphology was 
shown for mouse layer 1 neurogliaform and 
single bouquet neurons, using the patch–seq 
technique, which combines patch-clamp 
physiology and scRNA-seq76 (Fig. 3c). 
Finally, RNA-seq analysis of retrogradely 
labeled neurons in mouse primary visual 
cortex shows distinctive projections 
of transcriptionally defined excitatory 
subclasses40 (Fig. 3d). Experimental tools are 
Fig. 2 | transcriptomics classifications of cortical cell types. a, Single-cell transcriptome analysis reveals a molecular diversity of mouse cell types, with 
relatively invariant interneuron and non-neuronal types across cortical areas but significant variation in excitatory neurons. b, major interneuron classes are 
specified by distinct transcription factor codes. c, Single-cell transcriptomics of mouse GAbAergic interneuron development demonstrates gradual changes 
in gene expression underlying developmental maturation and fate bifurcations as cells become postmitotic. d, Gene families shaping cardinal GAbAergic 
neuron type include neuronal connectivity, ligand receptors, electrical signaling, intracellular signal transduction, synaptic transmission and gene transcription. 
These gene families assemble membrane-proximal molecular machines that customize input–output connectivity and properties in different GAbAergic 
types. e, Single-cell transcriptomics allows cross-species comparisons and shows conservation of major cell classes from reptiles to mammals, with conserved 
transcription factors but some species-specific effectors (turtle data). TF, transcription factor. Images in a and c adapted with permission from refs. 40,63, 
respectively, Springer Nature; in b, adapted with permission from ref. 27, elsevier; in d, adapted with permission from ref. 37, cell Press; in e, adapted with 
permission from refs. 30,68, elsevier and AAAS, respectively.
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increasingly available to aid in phenotypic 
characterization of transcriptionally defined 
cell types in model animals and even human, 
such as specific Cre lines and viruses, 
as well as novel spatial transcriptomics 
methods54,77. While major consortium efforts 
will generate the transcriptomic framework, 
linking different types of data to it will  
likely be most effective as a distributed 
community effort.
Challenges for cortical cell type 
classification
Although strong cross-modal 
correspondence has been observed at the 
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at the more refined branches of the 
transcriptomic classification remains largely 
to be validated. One example is the already 
mentioned RNA-seq study of retrogradely 
labeled neurons in mouse primary visual 
cortex40. Despite distinct projection targets 
at the major branches of the transcriptomic 
taxonomy, there were overlapping 















































Phenotypic correspondence by patch-seq
c
Transcriptome/connectivity relationshipsMultimodal cell type correspondence
db












i2 i1 i5 i3 i4 i7 i1
0







































































Elongated neurogliaform cells (eNGCs) Single bouquet cells (SBCs)
n cells 491 8 406 52 92
Injection
targets


















L4 IT VISp Rspo1
L2/3 IT VISp Agmat
L5 NP VISp Trhr Cpne7
L5 IT VISp Hsd11b1 Endou
L5 NP VISp Trhr Met
L5 IT VISp Batf3
L6 CT VISp Ctxn3 Brinp3
L6 IT VISp Penk Col27a1
L6 IT VISp Col18a1
L6 IT VISp Penk Fst
L6 IT VISp Car3
L2/3 IT VISp Adamts2
L2/3 IT VISp Rrad
L5 IT VISp Col27a1
L5 PT VISp Krt80
L6 CT VISp Ctxn3 Sla
L6 CT VISp Krt80 Sla
L6b P2ry12
L6 CT VISp Nxph2 Wls
L6 CT VISp Gpr139
L6b VISp Mup5
L6b Col8a1 Rprm
L5 IT VISp Whrn Tox2
L5 PT VISp C1ql2 Ptgfr
L5 PT VISp Chrna6
L5 IT VISp Col6a1 Fezf2
L5 PT VISp C1ql2 Cdh13
L5 PT VISp Lgr5
L6b Hsd17b2
L6b VISp Col8a1 Rxfp1
L6b VISp Crh


























Fig. 3 | Correspondence across phenotypes of cortical neuron types. a, Quantitative morphological clustering and electrophysiological feature variation between 
major inhibitory neuron classes using transgenic mouse lines (modified from Figs. 1 and 2 from ref. 31). b, convergent physiological, anatomical and transcriptomic 
evidence for a distinctive rosehip layer 1 inhibitory neuron type in human cortex that differs from neighboring neurogliaform cells. c, morphological and physiological 
differences between layer 1 neurogliaform and single bouquet neurons shown by patch-seq analysis. Scale bars as in b. d, rNA-seq analysis of retrogradely labeled 
neurons in mouse primary visual cortex show distinctive projections of excitatory subclasses, but overlapping projections for finer transcriptomic cell types. Images 
in a adapted with permission from ref. 31, Oxford Univ. Press; in b–d, adapted with permission from refs. 75,76 and 40, respectively, Springer Nature.
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types (Fig. 3d). One possible explanation 
is that long-range connectivity patterns are 
set up early in development and may not be 
strongly reflected in adult gene expression. 
However, such mismatches do not negate the 
value of a core transcriptomic classification 
as described above. Rather, this information 
about developmental trajectories needs to 
be incorporated into the transcriptomic cell 
type classification28.
Another challenge to transcriptomic 
classifications (and, in fact, to any 
classification of cell types) is the presence 
of phenotypic variation within a given cell 
type. One facet of this is the possibility of 
variation in gene expression due to cell 
state, differentiation and other dynamic 
processes within a single cell type. Some 
studies have suggested that cell types are 
possibly not defined, discrete entities and 
may be better described as components of 
a complex landscape of possible states78–80, 
and, indeed, some of that heterogeneity 
can be mapped with omics data81. Some 
continuous variation could be functionally 
relevant. For example, basal dendritic 
lengths and morphological complexity of 
layer 2/3 pyramidal cells appears to vary 
smoothly across a rostrocaudal axis in 
mouse cortex82 (Fig. 4a). Further evidence 
for spatial gradients can be found in the 
graded transcriptomic variation across 
the human cortex83, perhaps reflecting the 
expression of transcription factor gradients 
in the ventricular zone during development 
(Fig. 4b). These phenotypic or spatial 
gradients create challenges for thresholding 
in clustering, and they fuel debates between 
lumpers and splitters in determining the 
right level of granularity in defining  
cell types.
A particular advantage of a 
transcriptomic classification is that it 
provides a direct avenue for quantitative 
comparative analysis by aligning cell 
types across species based on shared gene 
covariation, enabling an ‘Ur-classification’ 
as a common denominator of basic cell 
types. For example, a recent study of human 
cortex61 demonstrated that the overall 
cellular organization of the human cortex 
is highly conserved with that of the mouse, 
allowing identification of homologous cell 
types (Fig. 4c). However, this study also 
revealed a challenge for the future, in that, 
in many cases, it was not possible to align 
cell types across species at the finest levels 
of granularity but rather at a higher level in 
the hierarchical taxonomy. Furthermore, 
many differences were seen in homologous 
types, including their proportions, 
laminar distributions, gene expression and 
morphology. Finally, prominent differences 
were found in non-neuronal cells as well, 
including astrocyte diversity and divergent 
molecular phenotypes between mouse 
and human that correlate with known 
morphological specializations in primate 
astrocytes36,74,84. Such similarities and 
differences between cell types across species, 
as well as challenges created by graded or 
developmental variations in features, could 
also be better captured by a probabilistically 
defined and hierarchically organized 
cell-type taxonomy.
a probabilistic and hierarchical  
definition of cortical cell types
Examining the current transcriptomic 
evidence, in some cases we find highly 
distinct cell types based on robust 
similarities of the transcriptome and other 
measurable cell attributes, as exemplified 
by the phenotypic homogeneity of 
neocortical chandelier cells40,85–87 or the 
above-mentioned rosehip cells. On the other 
hand, the existence of cell states, spatial 
gradients of phenotypes and mixtures of 
differences and similarities in cross-species 
comparisons present challenges to a 
discrete and categorical perspective on 
defining cell types. Prematurely adopting 
an inflexible definition of types will obscure 
the significance of observed phenotypic 
variability and its biological interpretation. 
Rather, a plausible way forward is to employ 
a practical or operational quantitative 
definition of a cell type.
Cluster analysis has been used to 
classify cortical neurons according to their 
structural or physiological phenotypes or 
expression of molecular markers13,14,22,31,82,87–90 
and, more recently, transcriptomics36,40,91,92. 
Many unsupervised and supervised 
methods can be used, including multilayer 
perceptrons16, logistic regression16, k-nearest 
neighbors16, affinity propagation93, 
Bayesian classifiers34, naïve Bayes16, topic 
modelling94, t-distributed stochastic 
neighbor embedding (t-SNE)95,96, graph 
theory97 and autoencoders98. These methods, 
building on the existence of statistically 
defined groups or clusters over a set of 
measurable attributes, naturally lead to an 
evidence-based probabilistic definition  
of cell types.
A probabilistic definition of cell types is 
particularly applicable to transcriptomics, 
where the dimension of the underlying 
space is large, the variance comparatively 
high and competing approaches give similar 
results. However, one requires community 
consensus on a rigorous statistical definition 
of transcriptomic types and the description 
of intra- and inter-type variability. Ideally, 
this quantitative definition of a cell type 
would be independent of the statistical 
method used (i.e., robust to different 
methods) and would include a description 
of quantitative metrics such as resolution, 
complexity, variability, uniqueness and 
association of variables with other attributes. 
There are two approaches to find and test 
cluster validity. One is ‘hard’ clustering, with 
clearly defined borders between clusters and 
with each cell strictly assigned to a particular 
type. Alternatively, in ‘soft’ (or ‘fuzzy’) 
clustering, any given cell has a particular 
probability of belonging to a particular 
cluster. Despite the probabilistic nature, 
inter- and intra-cluster distance may still be 
defined for outcome validation. Ultimately, 
the consensus description of cell types may 
form a continuum, beginning with hard and 
ending with soft distinctions among cell 
types, with an ambiguous transition between 
these extremes.
One natural approach to represent a 
transcriptomic taxonomy is to adopt a 
hierarchical framework. Cluster analysis is 
well suited to this, as its connectivity-based 
methods generate a tree-like representation 
of clusters99. This approach follows the 
historical tradition of using cladistics to 
classify organisms, assuming common 
ancestors in their evolution and 
synapomorphies (shared derived traits) 
among related clades. While statistical 
clusters do not presume any hierarchy in the 
structure of the data, biological systems have 
a temporal evolution as one of their essential 
features and makes temporally based 
hierarchies natural100. The evolutionary or 
developmental history of a neural circuit 
implies earlier stages, which are often less 
specialized and represent common ancestors 
of later states101. Indeed, a hierarchical 
organization of existing transcriptomic cell 
types data appears to mirror developmental 
principles and spatiotemporal organization 
in the neocortex (see above). Another 
advantage of casting the cell type 
classification as a cladistic one is that the 
lumping–splitting tension maps itself 
naturally as a distinction between different 
levels of the hierarchical tree, since one can 
split a group into subgroups at a lower level 
of the hierarchy to reflect data obtained in 
different physiological or developmental 
conditions. This provides an effective and 
objective framework to quantitatively 
evaluate lumper-vs-splitter discussions.
But hierarchical transcriptomic 
relationships may not be easily represented 
as a simple tree-like structure. Rather, they 
may have complex inclusion–exclusion 
and class relationships and may be 
more amenable to graph-based or other 
set-theoretic constructions. Indeed, the 
space of the transcriptomes for cortical 
cell types could be visualized as a complex, 
high-dimensional landscape with isolated 
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peaks of expression for a given cell type but 
also valleys and gradients between more 
weakly defined classes, which could be 
described alternatively as types or states. 
Such complexity can be described using, for 
example, the concept of cell-type attractors28, 
or using the distinction between core and 
intermediate cells40 or the description of 
a cell type as a continuous trajectory in 
transcriptomic space102. A robust statistical 
framework that enables a quantitative 
definition of cell type (or tendency to be a 
type) is clearly needed.
A final, and key, question is how to 
ensure that any given classification or 
taxonomy is valid. The goal is not defining 
a classification system per se, but to create 
a comprehensive description of cellular 
diversity in the neocortex. One needs to 
ensure that the experimental method will 
indeed capture all of the cell types present, 
that the classification is complete and that 
the types are defined correctly. For any 
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Inh L1−2 PAX6 CDH12
Inh L1−2 PAX6 TNFAIP8L3
Inh L1 LAMP5 NMBR
Inh L1−6 LAMP5 LCP2
Inh L1−2 LAMP5 DBP
Inh L2−6 LAMP5 CA1
Inh L1 SST CHRNA4
Inh L1−2 ADARB2 MC4R
Inh L1−2 SST BAGE2
Inh L1−3 VIP SYT6
Inh L1−2 VIP TSPAN12
Inh L1−4 VIP CHRNA6
Inh L1−3 VIP ADAMTSL1
Inh L1−4 VIP PENK
Inh L2−6 VIP QPCT
Inh L3−6 VIP HS3ST3A1
Inh L1−2 VIP PCDH20
Inh L2−5 VIP SERPINF1
Inh L2−5 VIP TYR
Inh L1−3 VIP CHRM2
Inh L2−4 VIP CBLN1
Inh L1−3 VIP CCDC184
Inh L1−3 VIP GGH
Inh L1−2 VIP LBH
Inh L2−3 VIP CASC6
Inh L2−4 VIP SPAG17
Inh L1−4 VIP OPRM1
Inh L3−6 SST NPY
Inh L3−6 SST HPGD
Inh L4−6 SST B3GAT2
Inh L5−6 SST KLHDC8A
Inh L5−6 SST NPM1P10
Inh L4−6 SST GXYLT2
Inh L4−5 SST STK32A
Inh L1−3 SST CALB1
Inh L3−5 SST ADGRG6
Inh L2−4 SST FRZB
Inh L5−6 SST TH
Inh L5−6 LHX6 GLP1R
Inh L5−6 PVALB LGR5
Inh L4−5 PVALB MEPE
Inh L2−4 PVALB WFDC2
Inh L4−6 PVALB SULF1
Inh L5−6 SST MIR548F2
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Fig. 4 | Challenges for transcriptomic classification. a, Gradients in morphological size and complexity across the rostrocaudal extent of the cortex. b, Graded 
transcriptomic variation across the human cortex encodes rostrocaudal position on the cortical sheet. c, Transcriptomic cell types can be aligned across 
species based on shared molecular specification, but often at a lower level of resolution than the finest types observed in a given species. Images in a adapted 
with permission from ref. 82, Oxford Univ. Press; in b and c, adapted with permission from refs. 83 and 61, respectively, Springer Nature.
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ensure accuracy and correctness. First, it 
is imperative to seek internal statistical 
robustness for identified clusters, using 
different statistical methods22,103. Second, 
external validation with orthogonal 
datasets is critical. Multimodal datasets 
are particularly important in this regard, 
as they enable cross-comparisons between 
classifications based on different types of 
data, for example, molecular, physiological 
or anatomical22,31, patch-seq76, or spatial 
transcriptomics methods54 (Fig. 3a–c) can 
enable this, defining functionally relevant 
levels of granularity. Finally, a probabilistic 
definition, particularly with a Bayesian 
framework, can be tested by generatively 
building computational models of each cell 
type and comparting them with the real 
data, thus providing some performance 
metrics on the algorithms. Using these 
criteria, robustness, reproducibility and 
predictive power can be measured and 
different approaches compared, as is 
normally done in machine learning16.
a unified ontology and nomenclature 
of cortical cell types
To truly gain community adoption, the 
data-driven transcriptomic classification of 
cortical cell types requires a formal unified 
cell type classification, a taxonomy and a 
nomenclature system17,20,90 whose principles 
are generalizable to other systems. Names 
are important: as an old Basque proverb 
states, ‘izena duen guzia omen da’ or ‘that 
which has a name exists’, and a similar 
Chinese one says ‘the beginning of wisdom 
is to call things by their right names’. This 
classification should aim to be a consensus 
one that incorporates the richness of data 
accumulated by different groups and be 
presented in a curated output that is public, 
easily accessible and has revisions managed 
by a curation committee of experts. Creation 
of such an ontology is a serious project in 
data organization that can build on prior 
efforts in cell ontologies104–106, as well as 
best practices established by the ontology 
development community107 (see Open 
Biomedical Ontology Foundry, http://www.
obofoundry.org).
A true, data-driven transcriptomic 
taxonomy poses a series of challenges 
that have not yet been taken on by the 
cell ontology community, but that are 
surmountable. One challenge is that 
transcriptomically similar cell types can 
exist in multiple anatomical locations. Thus, 
transcriptomic types need to be related to 
proper levels of the anatomical structure. 
Prominent gradients across cortical areas 
pose another challenge to define in a 
taxonomy. While any given cortical region 
contains some number of transcriptomic 
types, it seems likely that many of these 
types will vary in a somewhat continuous 
fashion across cortical areas and possibly 
also across species (Fig. 4a,b). Likewise, 
the classification system should also have 
a temporal component to capture the 
developmental trajectory from progenitor 
cell division to a terminally differentiated 
state. Cells can be quantitatively defined 
by their position on that developmental 
or spatial gradient. Finally, aligning across 
species is quantitatively possible now, but 
this alignment may only be possible at 
different levels of granularity with increasing 
evolutionary distance. The benefits of 
creating a unified reference ontology across 
these biological axes will be large, but it will 
be a serious community effort to design a 
system that can accommodate them.
Following the genetic classification 
paradigm proposed here, there are many 
lessons to learn from genomics. For 
example, the reference classification could 
be iteratively updated and refined with 
subsequent accumulation of data108 like 
genome builds, which changed in the early 
years but have become increasingly stable. 
As in current gene nomenclature, an official 
symbol with multiple aliases can link cell 
types to commonly used terminology 
relating to cellular anatomy or other 
phenotypes. This nomenclature should be 
portable across species, with orthologous 
cell types having common names, much as 
current gene symbols refer to orthologous 
genes. For the cell type classification 
to be useful like the genome has been, 
computational tools conceptually similar 
to BLAST alignment tools109 for mapping 
sequence data, need to be developed to 
allow researchers to quantitatively map their 
data to this reference classification. Finally, 
continuing the analogy with genomics, just 
as there are different versions of genome 
builds for different purposes (for example, 
with more or less manual curation), one 
could consider different versions of cortical 
cell type taxonomies, with varying levels of 
splitting or lumping; spatial, temporal or 
evolutionary criteria; or even some manually 
curated by experts, but under a unified 
framework of probabilistic definition  
of cell types.
Nomenclature also poses a challenge. 
Currently, the lack of standardized 
nomenclature makes it difficult to track 
and relate cell types across different studies. 
One natural idea with a genetically based 
paradigm is to name cell types on the basis 
of the best defining genes for each cell 
type, as is currently commonly done36,61,110. 
However, the most specific genes are not 
always detected in every cell of a cluster, and 
often the genes that best define a cell type 
in one species are not conserved in other 
species. The traditional way of naming cell 
types is by their anatomical features (such 
as chandelier, double-bouquet, basket, 
Martinotti, pyramidal cells), and it would 
be desirable to incorporate these short and 
widely-used names into a nomenclature 
when possible, to seek consistency with 
the vast literature on neocortical cell 
types. However, anatomical features, such 
as horsetail axons, may also vary across 
species17. Also, for newly identified cell 
types, anatomical information is often not 
available and naming them by marker genes 
will be more practical.
Adopting a more abstract nomenclature 
not based on anatomical features or 
individual marker genes could make it 
more flexible, more easily applicable across 
species and more compatible with other 
tissues outside the cortex or the brain. One 
idea for a cell-type nomenclature system 
is to build on gene nomenclature, treating 
transcriptomic cell clusters as sequence 
data (partially implemented for Allen 
Institute datasets; https://portal.brain-map.
org/explore/classes/nomenclature). Every 
cell cluster from a dataset or analysis 
would get a unique accession ID. Robust 
and reproducible clusters would have 
official cell type names or symbols, as 
well as any number of aliases that could 
represent different existing nomenclatures 
or historical names. In addition to cell 
types, higher-order classes (for example, 
caudal ganglionic eminence (CGE)-derived 
GABAergic interneurons, GABAergic 
interneurons, neurons) could be named as 
well, and both types and classes would be 
matched across species at the level (type, 
class) at which they can be aligned.
a cell-type knowledge graph for  
community data aggregation
Defining the cell types of the cortex 
(or other brain structures) serves as a 
foundation for aggregating information 
about their function. By analogy to the 
genome, the definition of genes has allowed 
a massive integration of information about 
their usage, function and disease relevance 
with a wide range of databases. On the other 
hand, probabilistically defined cell types are 
not the same as deterministically defined 
protein-coding regions of the genome, and 
we can expect that our understanding of 
cell types and their functional relevance 
will change as more information becomes 
available. A more flexible way to organize 
our knowledge and understanding of 
cell types would be as a living, updatable 
framework, one allowing reference, 
query and inference. An online-based 
data aggregation platform could also 
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have a significant sociological impact in 
neuroscience by encouraging collaborative 
participation.
One example of an appropriate data 
structure for such a community platform  
is a ‘knowledge graph’, a widely used tool in  
the tech industry and computer science  
as a platform for data aggregation (Fig. 5).  
A knowledge graph is a relational data 
structure in which nodes represent entities 
(such as cell types and their attributes) and 
the links, or edges, between them represent 
their relational and statistical associations. 
There is a measurable graph-theoretic 
distance between nodes based on probable 
associations and known relationships. The 
cortical cell knowledge graph could be 
initialized with standardized transcriptomics 
data, after which other data modalities and 
related taxonomies could be readily mapped 
onto the graph to capture anatomical, 
electrophysiological, developmental and 
other cell properties. For example, important 
contributors to cell identity, determined 
by cellular interactions, splicing, local 
translation, protein phosphorylation, etc., 
may not be readily captured by scRNA-seq 
at present, but could be measured in 
future CAP datasets, which could then be 
added to the knowledge graph. In such 
a knowledge graph, there are two basic 
use-cases as new data becomes available. 
First, one can use it to identify known cell 
types and their properties in new datasets. 
With a probabilistic or Bayesian definition, 
each new cell will be assigned a probability 
of belonging to a particular type in the 
graph. Second, the graph can be manually 
or automatically updated, following 
conventional optimization algorithms, as 
new data can change node identities and 
distances with respect to one another.
The proposed cell-type knowledge 
framework would represent a living and 
updatable resource that maintains an 
actively derived and flexible ontology of 
cortical cell types, benefitting from present 
active ontology efforts. This standardized 
database could be powered by open-source 
algorithms and managed and curated by 
database administrators. It would be a 
dynamic database with query capability, 
but would only accept peer-reviewed 
published data in a standardized fashion 
and nomenclature, providing a common 
denominator for the research in the field, 
integrating quantitative and qualitative 
cell-type classification, and allowing for 
updates, subject to review and validation. 
Computational engines would allow new 
data to be compared and allow users 
to query the current state of cell-type 
understanding from the perspective of 
their new data, assigning the most likely 
type to multi- or unimodal datasets based 
on similarities to the current framework’s 
knowledge. In addition to supporting 
literature reference, the dynamic framework 
might include online forums for scientific 
discussion and education. Ultimately, a 
cell-type community knowledge framework 
would be a dynamic and living resource that 
researchers, clinicians and educators could 
refer to as the benchmark resource for cell 
types in the cortex, promoting collaborative 
participation in the field.
Maintaining and updating the 
classification
The classification, nomenclature and 






















































































Fig. 5 | transcriptome based taxonomy, probabilistic cell types, and cell-type knowledge graphs. a, A transcriptome-based cell-type taxonomy is constructed 
from scrNA-seq data, related epigenomic datasets and neuroanatomy, b, cell types are initially defined based on transcriptomic signatures in a probabilistic 
manner with multiresolution clustering and statistical analysis to identify robustness and variability. c, reproducible gene expression patterns identify 
hierarchies of putative cell types that are subject to further analyses and validation. d, Transcriptomic cell-type taxonomies form a basis for constructing 
cell-type knowledge graphs that summarize the present state of definable cell types. multimodal assignment of data, such as morphology, electrophysiology 
and connectivity, is associated and reported with statistical variability over assigned types. A knowledge graph contains relevant and essential supporting 
information, such as supporting data for further analysis and mapping, descriptive annotation and ontology, and literature citations.
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managed by a committee of experts 
representing the breadth of approaches and 
disciplines in the field. Such a committee 
would be charged with designing the 
statistical classification model to sustain 
a basic taxonomy; the type of open 
platform to use for the knowledge graph; 
the rules by which this taxonomy can be 
updated and revised; the quality control or 
peer-reviewed criteria; and the metadata 
to be added. While the knowledge graph 
could continually update itself automatically, 
as new data is imported, different curated 
versions of the graph might be released in 
regular updates. This committee, arising 
from expert volunteers, could also help with 
vetting of a unified nomenclature of cortical 
cells that is succinct, useful and informative, 
as well as methods by which community 
input would be incorporated in a fair and 
efficient fashion.
Potentially, such a committee might 
be established and supported through 
existing organizations or consortia 
with interest in cell type classification, 
such as the NIH BRAIN Initiative Cell 
Census Network (BICCN; https://www.
biccn.org), the NeuroLex–International 
Neuroinformatics Coordinating Facility 
(INCF; http://130.229.26.15/news/activities/
our-programs/pons/neurolex-wiki.
html), the Neuroscience Information 
Framework (NIF; https://neuinfo.org), 
the Human Brain Project (HBP; https://
www.humanbrainproject.eu/), the Human 
BioMolecular Atlas Program (HuBMAP; 
https://commonfund.nih.gov/hubmap) or 
the Human Cell Atlas (HCA; https://www.
humancellatlas.org/). Some of these groups 
are already chartered with mapping the cell 
types of the nervous system or other organs 
in the body and may have resources to build 
the backend technological infrastructure 
needed for the knowledge graph.
Regardless of who supports and 
maintains this key infrastructure, it is 
critical that the efforts be managed through 
open communication with the community. 
A public consortium will be a logical 
organizational structure for channeling 
diverse inputs and will also adequately 
represent the wider community, reflecting 
cultural, geographic, ethnic and gender 
diversity. Strong community engagement 
will ensure wide acceptance and ensure that 
these standards are adopted widely, within 
and outside of the neocortex specialist field.
a community-based taxonomy and 
nomenclature of cortical cell types
To conclude, we think that the field of 
neocortical studies is ready for a synthetic, 
principled classification of cortical cell types, 
based on single-cell transcriptomic data 
and anchored on quantitative criteria that 
operationally define cell clusters based on 
their statistical and probabilistic grouping. 
Although molecularly driven initially, this 
taxonomy should be revised and modified as 
additional CAP datasets become available, 
becoming a true multimodal classification 
of cortical cell types. We view this core 
classification as potentially valid for all 
mammalian species and also as likely 
applicable to homologous structures in 
other vertebrates, as a broad framework to 
encapsulate evolutionary conservation with 
species specialization. Indeed, only with 
such a systematic approach to comparing 
cell types across species will it be possible to 
understand how cell type diversity evolved 
in the cerebral cortex.
This taxonomy will only be useful and 
successful if adopted by the community.  
So, in addition to the nomenclature, a series 
of research tools should be developed, 
ideally by a community consortium, to 
facilitate similar experimental access to 
these cell types by the broader range of 
investigators. We envision molecular and 
genetic tools, such as standard sets of 
antibodies and RNA probes to identify 
key molecular markers for each cell type, 
as well as cell or mouse lines that are used 
as resources for the entire community. 
Statistical tools to enable direct comparisons 
among datasets, and to enable mapping 
new datasets to reference datasets, are 
essential. An open informatics backbone 
needs to be developed as an essential part of 
the taxonomy, as well as visualization and 
analysis tools that take advantage of this 
taxonomy and allow scientists to explore  
the data, add to the knowledge base and 
achieve new knowledge.
In addition, we propose that the 
community input to support this taxonomy 
and enable its future revisions be channeled 
into an open platform, a knowledge graph, 
as is becoming increasingly common in 
community-led data science. Aggregation 
of knowledge through data graphs, now 
a common practice in the tech industry, 
will accelerate the dissemination of 
knowledge and could avoid the ‘publication 
graveyard’, where data are stored away 
in siloed journal articles disconnected 
from the rest of the field. Anchoring this 
taxonomy and knowledge graph, a unified 
new nomenclature of cortical cell types 
valid across species is needed to centralize 
efforts in the field, with a generalizable 
framework to integrate with other cell-type 
classifications. We view the establishment 
of a common nomenclature as an essential 
step to provide a standardized language that 
enables the meaningful aggregation and 
sharing of data.
If successful, this community-based 
classification effort, joined by a common 
nomenclature and nourished by the 
knowledge graph, could be extended and 
generalized to other parts of the brain or 
of the body. In this sense, the classification 
of neocortical cell types, a field with a long 
tradition and multidimensional approach 
to a central problem in neuroscience, could 
be an ideal test case to explore this novel 
organization of knowledge in neuroscience 
and, more generally, in biology. ❐
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